BAD Generic Drugs

Vaughn's Summaries *Medicine Summaries* *Pharmaceutical Drugs*
Bad Generic Drugs May Be Killing People This page is research in progress. More data is being added. by Vaughn Aubuchon
TOP 15 Generic Drug Manufacturers India Generic Drug Manufacturers (17) China Generic Drug Manufacturers (3) Ireland Generics (4) - U.S. Generics (8) Valsartan Recall Top API Manufacturers .	-
According to industry leader Mylan, 89% of all U.S. prescriptions are now filled with a GENERIC medicine. Our generic drugs are made by over 1,000 companies in China and India, AND many other countries, including Brazil, Canada, France, Hungary, Israel, Mexico, Slovakia, South Africa and Thailand. Generic drugs are SUPPOSED to be identical to their brand name counterparts. All too often, THEY ARE NOT. The U.S. FDA is tasked with approving and OVERSEEING these companies to keep us safe. They are TOTALLY FAILING to perform proper oversight. Because of this, we are being sold cr@pola. --- EXTREMELY little oversight --- Inadequate paper trail --- Specified quantity NOT PRESENT --- Pre-ingredients not fully vetted --- Contain UNNAMED ingredients* --- Procedures not followed** * such as, NDMA, NDEA as in the case of valsartan Why We Have Lost Confidence in Generic Drugs: New Report Casts More Doubts on Imported Medicines** .

top of page Top 15 Generic Drug Manufacturers - by Size ... from FiercePharma
Size	Company Name	2016 Bill. $	Head quarters	Note
1	Teva	9.8 B	Petah Tikva, Israel	#1API
2	Mylan (was Matrix)	9.4 B	Canonsburg, PA	# 2API
3	Novartis (Sandoz)	9.0 B	Basil, Switzerland	#8 API
4	Pfizer	4.6 B	NYC, New York
5	Allergan (Teva)	4.5 B	Dublin, Ireland
6	Sun Pharma (Ranbaxy)	3.6 B	Mumbai, India	#5 API
7	Fresenius	2.8 B	Bod Homburg, Ger.
8	Endo Inter.	2.6 B	Dublin, Ireland
9	Lupin	2.5 B	Mumbai, India
10	Sanofi (Apotex)	2.0 B	Paris, France
11	Aspen	2.0 B	Durban, S.A.
12	Aurobindo	1.8 B	Hyderabad, India	#3 API
13	Dr. Reddy's Labs	1.8 B	Hyderabad, India	#7 API
14	Cipla	1.6 B	Mumbai, India	#4 API
15	Apotex	1.6 B	Toronto, Ont.
	Top 15	59 B
?	Accord Healthcare	?	Durham, NC	47 drugs
?	Ranbaxy Labs	?	India	#6 API
?	Dexcel Pharma	?	Israel	85 drugs
	Notes - (rank) API - Active Pharmaceutical Ingredient manufacturer Not only do these companies make the pharma drugs, they ALSO make the Active Ingredients from which the drugs are made. (Fox guarding the henhouse? You betcha.) .
40	150 - 450	50	130	60

top of page INDIA Generic Drug Manufacturers - with KNOWN Issues More Drug Recalls from India
Company Name	# of FDA Warn-ing Letters	Location (# of employ.)	Class Problem Generic Name	REAL Drug Replaced - Mfg.	Possible ID on Bottle
Alembic Pharma	4	Gujarat, IN 9 K	API Mfg.		ALEM
Anwita Drugs		Hyderabad, IN ??			ANW
(12) Aurobindo	7	Hyderabad, IN 16 K			AURO
Cadila Healthcare	7	Ahmedabad, IN 13 K			CADI
(14) Cipla	12	Mumbai, IN 22 K		Ranked #3	CIP
(13) Dr. Reddy	80	Hyderabad, IN 20 K		Ranked #4	REDD ?
Hetero (Camber)	41	Hyderabad, IN 15 K	ARB - (old) valsartan	Diovan - Novartis	CAMB
Lupin		Mumbai, IN ??		Ranked #1	LUP
Macleods	7	Mumbai, IN ??	ARB - (new) valsartan		MACLE
NuCare Labs	1	Gujarat, IN xxx			NUC
Par Pharma Purchased by Endo		Chennai, IN 3.7 K	CCB - (new) diltiazem er		PAR
Polydrug Labs	23	Mumbai, IN ??			POLY
Ranbaxy	38	Gurgaon, IN 11 K			RANB
RPG Life Sciences	3	Mumbai, IN 750			RPGL
(6) Sun Pharma	173	Mumbai, IN 53 K		Ranked #2	SUNP
Torrent	8	Ahmedabad, IN 9 K	CCB - (old) diltiazem er	Cardizem CD - Valeant	TORRE
Wockhardt	38	Mumbai, IN 8 K			WOCK
Notes:
100 - 550	50	80	80	80	60

top of page CHINA Generic Drug Manufacturers .
Company Name	# of FDA Warn-ing Letters	Location	Class Problem Generic Name	REAL Drug Replaced - Mfg.	Possible ID on Bottle
Solco Health Huahai	2	?????, China	ARB - losartan	Cozaar - Merck	SOLCO
Zhejiang Huahai Pharma	Sept. 28, 2018 FDA Bans MORE Valsartan Imports
Zhejiang Tianyu Pharmaceutical Co.

top of page Ireland Generic Drug Manufacturers .
Actavis		Dublin, Ireland 22 K			ACT
(5) Allergan	41	Dublin, Ireland 17 K			ALLE
(8) Endo Intern.	144				ENDO
Perrigo	33	Dublin, Ireland 10 K			PERR
Gavis Pharma		Acquired by Lupin 2016
100 - 550	50	80	80	80	60

top of page U.S. Generic Drug Manufacturers .
Company Name	# of FDA Warn-ing Letters	Location	Class Problem Generic Name	REAL Drug Replaced - Mfg.	Possible ID on Bottle
Amneal Pharma		Bridgewater, NJ 6,500			AMN
(8) Endo Intern. (Par Pharma)	144	Woodcliff Lake, NJ 775	CCB - diltiazem er	Cardizem CD Valeant	PAR
Heritage Pharma		Eatontown, NJ xxx			HER
Lucid Pharma		E. Brunswick, NJ xxx			LUC
Major Pharma		Livonia, MI xxx			MAJ
Northwind		Indianapolis, IN xxx	Repackager		NW
NuCare Pharma		Orange, CA 14			NUC
Prinston Pharma	2	Cranbury, NJ xxx			PRIN

top of page OTHER Generic Drug Manufacturers - with KNOWN Issues
(15) Apotex	65	Toronto, CAN 10 K			APOT
(11) Aspen		Durban, S.A. xxx			ASP
(10) Sanofi	189	Paris, France 22 K			SAN
Notes:	API	Active Pharmaceutical Ingredients
100 - 550	50	80	80	80	60

top of page Valsartan Recall (generic Diovan) - due to NDMA, a carcinogen It's a total hodge-podge. Some of these recalled suppliers (UCM615703.pdf - Aug. 8, 2018) ALSO supply NON-recalled versions of valsartan, as shown below. So, it is quite a bag of worms. Sept. 28 - FDA Bans MORE Valsartan Imports ARB Drugs Recall Summary Irbesartan - UCM629626.pdf (third ARB recalled) Losartan - UCM628993.pdf (second ARB recalled) Valsartan - UCM615703.pdf (first ARB recalled) .
Company Name of Generic Seller	Parent	Recalled?	Date	ID on Bottle
Actavis	Teva (+ HCTZ) 13 meds	YES	July and August 2018	ACT
A-S Medic. Solutions	4 meds	YES		ASMS
AvKARE	(+ HCTZ) 5 meds	YES		AVKA
Bryant Ranch Prepack	Repackager 7 meds	YES		BRY
Camber Pharma	4 meds	YES		CAMB
Major Pharma	Teva 2 meds	YES		MAJ
Northwind Pharma	Repackager 4 meds	YES		NORW
NuCare Pharma	Repackager 3 meds	YES		NUC
Pharma Pac	HJ Harkins 1 med	YES		PHAR
Prinston	Teva	YES		PRIN
Proficient Rx	Repackager 1 med	YES		PROF
Remedy Repack	(+ HCTZ) 2 meds	YES		REM
Solco Health	Prinston 9 meds	YES		SOL
Torrent	Torrent 12 meds	YES		TORR
Notes:	API = Active Pharmaceutical Ingredient The included, unintended ingredient is NDMA = nitroso-di-methyl-amine This substance may have been present in the API valsartan AND UNDETECTED for OVER 4 YEARS, due to an unauthorized, untested, unmonitored process change.
	Sept. 13, 2018 A SECOND unintended carcinogenic ingredient has been identified from Huahai - NDEA - nitroso-di-ethyl-amine
	The TAINTED API's came from China, from First Identified China Flawed Generic Producer - Zhejiang Huahai Pharmaceuticals, Linhai, China Highest NDMA concentration ALSO, contaminated by NDEA. .
	Second Identified Flawed Generic Producer - Zhejiang Tianyu Pharmaceutical Co., Taizhou, China Lower NDMA concentration .
. Valsartan NOT Recalled (UCM615704.pdf - Aug. 8, 2018)
Alembic Pharma	26 meds	NO	n.a.
Allergan	1 med	NO
Amer. Health Pkg.	4 meds	NO
Amneal Pharma	4 meds	NO
Aphena Pharma	5 meds Repackager	NO
Apotex Pharma	6 meds	NO
Aurobindo	18 meds	NO
AvPAK	18 meds	NO
Camber Pharma	4 meds	NO	n.a.
Cardinal Health	2 meds	NO
Carilion Materials	2 meds	NO
Gavis Pharma	4 meds	NO
Jubilant Cadista	4 meds	NO
Lucid Pharma	4 meds	NO
(9) Lupin	18 meds	NO
Macleods Pharma	9 meds	NO
Mylan added	13 meds	NO
Northwind Pharma	4 meds	NO	n.a.
Novartis Pharma	21 meds	NO
Novel Labs	4 meds	NO
Ohm Labs	4 meds	NO
Par Pharma	9 meds	NO
PD-Rx	5 meds	NO
Preferred Pharma	4 meds	NO
Proficient Rx LP	9 meds	NO
Sandoz	18 meds	NO
Unichem Pharma	4 meds	NO
	THIS IS NOT A "WHITE LIST". NDMA MAY YET BE DETECTED. ALSO, NDEA has been detected. WHO did they buy their API from? (Active Pharmaceutical Ingredient = valsartan) WHICH manufacturer? WHICH batch?
150 - 550	100	80	60	60

top of page TOP API Manufacturers (Active Pharmaceutical Ingredients)
Rank	Company	Coun-try	# of APIs	Note	-
1	TAPI	Israel 21 others	300	Teva
2	Mylan Labs	India	???	was Matrix
3	Aurobindo	India	200
4	Cipla	India	200
5	Sun Pharma	India	200
6	Ranbaxy Labs	India	100
7	Dr. Reddy's	India	60
8	Sandoz	Switz.	20	Novartis
50	140 - 450	50	50	90	20

Disclaimer:
The author is not a doctor.
NO MEDICAL ADVICE IS OFFERED OR IMPLIED.
Data on this page may NOT be 100% correct.
These are just my personal thoughts.
The purpose of this page is to research bad generic drugs.

The buy-outs, strategic partnerships, and ever-changing ownership of generic drug companies have created a virtual MINEFIELD of drugs for the consumer, who has less and less control of what he is PUTTING INTO HIS/ HER MOUTH. Combine this with less and less scrutiny by the FDA, and we are taking a crapshoot, when using these meds.

I hope that you have found this generic drug information page helpful.
Thank you very much for your time.

top of page

This Vaughns BAD Generic Drug
Chart was last updated on 2020-07-06.